Ondas Holdings (ONDS) stock jumps on $10 million order news — what investors watch next

Ondas Holdings (ONDS) stock jumps on $10 million order news — what investors watch next

NEW YORK, January 1, 2026, 05:36 ET — Market closed

Ondas Holdings Inc shares closed up 8.6% at $9.76 on Wednesday after the Nasdaq-listed company flagged fresh orders in its autonomous systems business. The stock traded between $9.17 and $10.53, with roughly 156 million shares changing hands, ahead of a New Year’s Day market holiday. StockAnalysis+1

The move puts Ondas back in focus as investors look for signs that demand for defense and critical-infrastructure drone technology is turning into repeatable revenue, not just one-off wins.

That matters now because small-cap defense tech names can swing sharply on contract headlines, and traders are watching whether order flow holds up as budgets reset for 2026.

In a statement on Wednesday, Ondas said it had received about $10 million in new purchase orders across its autonomous systems portfolio, spanning counter-UAS (counter-drone) solutions, integrated drone systems and robotic ground platforms. “These new orders underscore the sustained, global demand we are seeing,” Chairman and CEO Eric Brock said, while the company also pointed to $16.4 million in fourth-quarter airport-related orders and said it expects an initial purchase order in January 2026 for a large-scale border-protection system deploying thousands of drones. Ondas Holdings Inc.

Counter-UAS is industry shorthand for technology designed to detect, track or defeat hostile drones. The theme has drawn attention as governments and operators of sensitive sites look for ways to harden airspace and perimeter security.

A separate regulatory filing showed Brock sold 475,000 shares on Dec. 31 at a weighted average price of about $9.71, with the filing describing the sale as covering tax obligations tied to a prior exchange transaction. SEC

Insider sales can spook momentum traders, but investors often weigh the stated reason and the executive’s remaining stake when judging signal versus noise.

Before the next session on Friday, investors will watch for follow-through buying and any additional detail on delivery timing — the difference between an order announcement and revenue recognition often comes down to when systems ship and are accepted.

From a chart-watching perspective, traders are likely to focus on whether Ondas can hold above the $9 area and make another run at Wednesday’s $10.53 intraday high.

Investors are also tracking potential share supply: a Dec. 17 filing said some holders elected to defer the closing of exchange transactions to Jan. 5, 2026, when the company expects to issue about 2.39 million additional shares. Ondas Holdings Inc.

Ondas has not listed a next earnings date on its investor calendar, leaving the next formal update on revenue conversion and cash burn dependent on future company scheduling. Ondas Holdings Inc.

Stock Market Today

  • Palantir stock faces limited upside despite strong growth and high valuation
    January 1, 2026, 7:28 AM EST. Palantir Technologies (PLTR) stock surged 149% in 2025, but analysts see limited upside ahead. The median 12-month target sits at $200, about a 6% gain, with roughly a quarter of 27 analysts rating it a buy and two-thirds a hold. Valuation remains rich - 435x trailing earnings versus 45x for the sector - though the forward multiple of 188x reflects expected growth. The company justifies the premium with strong unit economics: adjusted operating margin rose 13 percentage points to 51% in Q3, while revenue grew 63%. Palantir's Rule of 40 sits at 114%, well over the 40% threshold, helped by a 45% year-over-year rise in customers deploying its AIP platform.
Western Digital stock today: WDC slips after year-end drop as New Year’s Day shuts markets
Previous Story

Western Digital stock today: WDC slips after year-end drop as New Year’s Day shuts markets

Pfizer stock today: PFE in focus as 2026 U.S. drug price hikes kick off — what to watch next
Next Story

Pfizer stock today: PFE in focus as 2026 U.S. drug price hikes kick off — what to watch next

Go toTop